The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
May June set to be an overload of news almost) Encouraging about resource update this Q. Increase in mine life from 12 years to...? Len mentioned Goulamina and theirs is 20 I believe.
Plus $1500/t spod on conservative side once in production according to KM
I think offtaker interest is in securing supply for 2026, when according to forecasts spod to be in higher demand. ALL were also clear with their terms from the outset. They're looking for a strategic partner, not going to the market cap in hand so to speak. They could walk away in fact, knowing that sales will start from DMS Q1 2025 plus the further investment from MIIF due
I think they're pretty confident of spod reaching 2000/t by end of year, which would make huge difference to sp.
Disappointing on gold emphasis nonetheless. Sounds like news on Fatou and Nielle coming this year, but wasn't the extra cash for development of these projects
Agree each to their own. A 100% return at these levels in the space of a few months, very nice thankyou why not cash in.
Ratification imo is acting like a handbrake on the sp. That needs to be cleared up so that the other catalysts can have full effect, if and when they all happen.
Plus a keen eye on the daily spodumene price. Got the jitters yesterday when it fell slightly but glad to see it rose again overnight and is just short of $1100/t now.
Thanks for posting. Enjoyed watching, got to the nitty gritty so to speak and its good to know that work is going on behind the scenes re ratification process, committee etc even though parliament not in session I believe.
40p just sounds a bit naff to me the more I think about it. If it were forthcoming.
Feldspar by the sounds of it from Neil's voxmarkets interview could be a bit less than hoped for, but reduction in costs nonetheless. Will see in the study.
Looking forward to the updates
Thanks Teddy. Expectation is parliamentary ratification in the next couple of months according to Neil which was the only part new to me. Maybe in March.
Very undervalued at 21p and spod price increase not being reflected.
Imo the Feldspar study has the potential to bring costs down even further from $675. Expected this quarter.
Alot of news flow to come.
Listening to Vox podcast Jan 24 the day before NH went on, John Meyer suspecting negotiations behind the scenes but also Justin Waite:
"I'm chatting to Neil soon...obviously he won't be able to say too much. But maybe he'll be able to work on nuance and suggestion."
And John Meyer hinting at twice current mcap:
"now the group has 130m market cap. I'm sure it's worth at least twice that..."
Regarding offtake partner:
"Lots of companies in the data room...because we're nomad and broker to the company we're very close to what's going on"
https://www.voxmarkets.co.uk/series/daily-podcast/
From 11.30
Gaias, thing is that they would have calculated that before the previous offers, yet still offered 33p, unless those were not serious offers?
If they paid Piedmonts share of the 185m then they could still add value to it with the 50% offtake they'd get. That's what SPAngel were suspecting in this weeks release, although rumoured and may not actually be their intention
I think some of the bod average is in low 20s, would 40p do it for them. I'd be a bit miffed (pun intended) at 40 personally. New board member Jonathan Henry would i guess be no sooner in than out the door? Makes me wonder among other things that maybe 40 would be rejected too?
Creep acquisition is also an exception apparently, allowing accumulation shares. But that would mean waiting until July for another purchase of shares? Why wait? Are they saying ratification may not happen? If so, why do they want to buy?
Actually want them to get on with it as it can't be good for MIIF sign off or even government, wondering who they are to be dealing with
End of this Q1, if ratification achieved (ruling party has slim but nevertheless 1MP majority), Ghana listing, Feldspar economics released, MIIF sign off, offtake partner with pre-payment, resource upgrade, then 21p it should be nowhere near. Imo
Bentnose thanks for posting, yes, looks like it doesnt apply as registered in Australia:
https://code.thetakeoverpanel.org.uk/tp/introduction/section-3.html
Thanks for posting Teddy. Also SPangel saying it doesn't apply:
"UK investors are concerned that Assore might breach 30%, though UK takeover provisions do not apply in this case. Assore has bought the maximum that the 3% creep provision will allow every 6 months.”
Not2sure thanks for posting, yes it is the price the bidder paid in previous 12 months
Only thing unclear to me is how are Assore permitted to hold more than 20% under Oz corporation rules? Can only be under an exception (takeover offer) which would mean one is imminent as part of that Piedmont purchase?
Smart, it's what I thought but there is nothing written in AIM rules or listing rules I could find saying Takeover Code is mandatory
In ALL constitution there is undertaking to follow AIM rules too whilst listed. I'm assuming Takeover Code applies?
https://www.atlanticlithium.com.au/gm-notices